APP and Cognitive impairment: Most animal models of AD, based on human mutations of either amyloid precursor protein (APP) or presenilin-1 (PS1), show progression of amyloid plaques and abnormal behavior, similar in many ways to the human aspects of worsening from normal aging to mild cognitive impairment (MCI) to frank dementia [14].